Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B

Infection and Immunity

Volumn 69, Issue 1, 2001, Pages 336-344

  Sun, Y ^a   Hwang, Y I ^a   Nahm, M H ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL CELL WALL; CROSS REACTION; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BACTERIAL CAPSULES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYBRIDOMAS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PHAGOCYTOSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035171711     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.1.336-344.2001     Document Type: Article

References (38)

1. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
2. The role of antibody concentration and avidity in antiviral protection
3. Molecular size analysis of capsular polysaccharide preparations from Streptococcus pneumoniae
4. Emergence of drug-resistant pneumococcal infections in the United States
5. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae
6. The classical complement pathway: Activation and regulation of the first complement component
7. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults
8. Degeneracy in the secondary immune response: Stimulation of antibody formation by cross-reacting antigens
9. Disquisition on original antigenic sin. I. Evidence in man
10. Pneumococcal vaccine
11. Infant pneumocoecal vaccine
12. Functional affinity of antibody to the Haemophilus influenzae type b polysaccharide
13. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
14. Six newly recognized types of Streptococcus pneumoniae
15. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b
16. Fcγ-receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera
17. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
18. Biological correlates of capsular (Quellung) reactions of Cryptococcus neoformans
19. Monoclonal antibodies to streptococcal group A carbohydrate. I. A dominant idiotypic determinant is located on Vk
20. A new method of applying the Sips equation
21. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae
22. A modified Farr assay is more specific than ELISA for measuring antibodies to S. pneumoniae capsular polysaccharides
23. Repertoire diversity of antibody response to bacterial antigens in aged mice III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae
24. The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B
25. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity
26. An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study
27. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
28. The contribution of ER quality control to the biologic functions of secretory IgM
29. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups
30. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells
31. Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity
32. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity
33. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines
34. Pneumococcal disease: Prospects for a new generation of vaccines
35. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides
36. Inadequacy of traditional ELISA for screening hybridoma supernatants for murine monoclonal antibodies
37. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae
38. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic